Application of systemic treatment in conversion therapy options for liver cancer

• Published in: Frontiers in oncology Vol. 12; p. 966821
• Main Authors: Bei, Haoyang, Mai, Weiheng, Chen, Weifeng, Li, Mingyi, Yang, Yongguang
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 06.10.2022
• Subjects: conversion therapy; downstaging; Oncology; primary liver cancer; surgical resection; systemic treatment
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2022.966821

Radical hepatectomy is the main treatment method to improve the prognosis of patients with intermediate and early-stage liver cancer. Most liver cancer patients in China are in the advanced stage at the initial diagnosis, losing the opportunity for surgical treatment. Therefore, it is essential to down-stage unresectable liver cancer to resectable liver cancer clinically, which is an important way to improve patients’ survival and a hotspot of current clinical research. In recent years, with the increase in effective treatment methods for liver cancer, the resection rate of conversion surgery for unresectable advanced liver cancer has been significantly improved, and a growing number of patients benefit from conversion therapy. This article mainly reviews the connotation of conversion therapy for liver cancer, the patient selection, the selection of conversion strategy, the timing of sequential operations, the scheme and safety, etc.